Azore is a software tool designed for computational fluid dynamics (CFD) that focuses on the analysis of fluid movement and thermal transfers. By utilizing CFD, engineers and scientists can numerically tackle a diverse array of problems related to fluid mechanics, thermal dynamics, and chemical interactions through computer simulations. Azore excels in modeling a variety of fluid dynamics scenarios, encompassing air, liquids, gases, and flows containing particles. Its applications are vast, including the modeling of liquid flow through piping systems and assessing water velocity profiles around submerged objects. Furthermore, Azore is adept at simulating the behavior of gases and air, allowing for the exploration of ambient air velocity patterns as they navigate around structures, as well as examining flow dynamics, heat transfer, and mechanical systems within enclosed spaces. This robust CFD software can effectively model nearly any incompressible fluid flow scenario, addressing challenges associated with conjugate heat transfer, species transport, and both steady-state and transient flow conditions. With such capabilities, Azore serves as an invaluable asset for professionals in various engineering and scientific fields requiring precise fluid dynamics simulations.
Learn more
SPEC Innovations offers a premier model-based systems engineering solution aimed at helping your team accelerate time-to-market, lower expenses, and reduce risks, even when dealing with the most intricate systems. This solution is available in both cloud-based and on-premise formats, featuring an easy-to-use graphical interface that can be accessed via any current web browser.
Innoslate provides an extensive range of lifecycle capabilities, which include:
• Management of Requirements
• Document Control
• System Modeling
• Simulation of Discrete Events
• Monte Carlo Analysis
• Creation of DoDAF Models and Views
• Management of Databases
• Test Management equipped with comprehensive reports, status updates, outcomes, and additional features
• Real-Time Collaboration
Additionally, it encompasses numerous other functionalities to enhance workflow efficiency.
Learn more
SYNTHIA Retrosynthesis Software
SYNTHIA™ Retrosynthesis software, created through the collaboration of computer scientists and chemists, empowers researchers to swiftly explore new and established pathways for target molecules. This tool enables efficient scanning of numerous pathways, helping to pinpoint the most suitable options tailored to specific requirements. With advanced visualization and filtering capabilities, users can uncover the most economical route to synthesize their desired molecule. The platform also allows for the customization of search parameters, enabling the user to either exclude or emphasize particular reactions, reagents, or molecular classes. Additionally, it presents innovative and distinctive synthetic routes to construct the target compound. Users can effortlessly generate a list of commercially available starting materials needed for their synthesis projects. Furthermore, the ISO/IEC 27001 Information Security Certification ensures the utmost confidentiality, integrity, and security of all data processed within the software, providing peace of mind to its users. This commitment to data protection reinforces the software's value in the scientific community.
Learn more
Atomwise
Our cutting-edge AI platform is transforming the drug discovery landscape, allowing us to create high-quality medications more rapidly than ever before. Backed by a wide array of discovery assets, both independently owned and co-developed with partners, and supported by prestigious investors, we are making considerable advancements in the sector. Atomwise has developed a machine-learning discovery engine that harnesses the power of convolutional neural networks in conjunction with vast chemical libraries to pinpoint new small-molecule drugs. The true potential of AI in revolutionizing drug discovery is rooted in the dedication and expertise of our team. We are committed to developing state-of-the-art AI tools that enhance the discovery of small molecules, targeting some of the most challenging and seemingly impossible objectives while optimizing the overall drug development process. By increasing computational efficiency, we can digitally screen trillions of compounds, significantly improving the likelihood of successful outcomes. Our models have achieved exceptional accuracy, effectively reducing the occurrence of false positives and setting the stage for groundbreaking medical innovations. As we continue to refine our technology, our ultimate goal is to equip researchers with the necessary tools to inspire innovation and deliver impactful results in the realm of drug discovery. This commitment to advancing the field is at the core of our mission.
Learn more
